E. coli Infection After Prostate Biopsy: Risks, Symptoms, Treatment

E. coli prostatitis is a recognized but uncommon complication of transrectal prostate biopsy (incidence 1–4% with prophylaxis).

Mechanism

Needle passage through the rectal mucosa can translocate colonic flora (predominantly E. coli) into the prostate, bloodstream, or urine. Rising fluoroquinolone resistance has increased infection rates.

Symptoms (Typically 24–72 Hours Post-Biopsy)

• Fever, chills, rigors
• Dysuria, frequency, urgency
• Perineal or rectal pain
• Cloudy or foul-smelling urine, hematuria
• Hematospermia
• Sepsis signs: hypotension, confusion (medical emergency)

Diagnosis

• Urine and blood cultures
• PSA (often elevated)
• Imaging if abscess is suspected

Treatment

• Empiric IV antibiotics (carbapenem, piperacillin-tazobactam, or aminoglycoside plus ceftriaxone) pending cultures
• Oral step-down therapy (14–28 days total)
• Hospitalization for sepsis
• Drainage if abscess forms

Prevention

• Targeted antibiotic prophylaxis based on local resistance patterns
• Rectal preparation (enema, povidone-iodine)
• Consider transperineal approach (lower infection risk)

Contact your urologist immediately for post-biopsy fever or systemic symptoms.